2019-nCoV is the causative agent of the serious, still ongoing, worldwide coronavirus disease (COVID-19) pandemic. High quality recombinant virus proteins are required for research related to the development of vaccines and improved assays, and to the general understanding of virus action. The receptor-binding domain (RBD) of the 2019-nCoV spike (S) protein contains disulfide bonds and N-linked glycosylations, therefore, it is typically produced by secretion. Here, we describe a construct and protocol for the expression and purification of yellow fluorescent protein (YFP) labeled 2019-nCoV spike RBD. The fusion protein, in the vector pcDNA 4/TO, comprises an N-terminal interferon alpha 2 (IFNα2) signal peptide, an eYFP, a FLAG-tag, a human rhinovirus 3C protease (HRV3C) cleavage site, the RBD of the 2019-nCoV spike protein and a C-terminal 8x His-tag. We stably transfected HEK 293 cells. Following expansion of the cells, the fusion protein was secreted from adherent cells into serum-free medium. Ni-NTA immobilized metal ion affinity chromatography (IMAC) purification resulted in very high protein purity, based on analysis by SDS-PAGE. The fusion protein was soluble and monodisperse, as confirmed by size-exclusion chromatography (SEC) and negative staining electron microscopy. Deglycosylation experiments confirmed the presence of N-linked glycosylations in the secreted protein. Complex formation with the peptidase domain of human angiotensin-converting enzyme 2 (ACE2), the receptor for the 2019-nCoV spike RBD, was confirmed by SEC, both for the YFP-fused spike RBD and for spike RBD alone, after removal of YFP by proteolytic cleavage. Possible applications for the fusion protein include binding studies on cells or in vitro , fluorescent labeling of potential virus-binding sites on cells, the use as an antigen for immunization studies or as a tool for the development of novel virus- or antibody-detection assays.
【저자키워드】 fluorescent spike RBD fusion protein, YFP-spike_RBD, protein reagent for COVID-19 research, 2019-nCoV spike-RBD production using standard cell culture equipment and techniques, secreted glycosylated YFP-labeled protein, mammalian protein secretion, 【초록키워드】 COVID-19, coronavirus disease, ACE2, Vaccine, pandemic, protocol, 2019-nCoV, protease, in vitro, virus, immunization, Antigen, Protein, cells, RBD, Microscopy, Research, receptor, experiment, fusion protein, Interferon alpha, expression, binding, Analysis, disulfide bond, signal peptide, secretion, domain, human Angiotensin-converting enzyme, cleavage site, IFNα2, fluorescent, staining, purification, 2019-nCoV spike protein, proteolytic cleavage, Human rhinovirus, N-terminal, labeling, Cell, N-linked glycosylation, SDS-PAGE, produced, include, assays, required, the RBD, C-terminal, adherent cell, FLAG-tag, Ni-NTA, SEC, secreted, secreted protein, serum-free medium, 【제목키워드】 spike, 2019-nCoV, characterization,